The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Proportional Hazards Models

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Proportional Hazards Models


Psychiatry related information on Proportional Hazards Models


High impact information on Proportional Hazards Models


Chemical compound and disease context of Proportional Hazards Models


Biological context of Proportional Hazards Models


Anatomical context of Proportional Hazards Models


Associations of Proportional Hazards Models with chemical compounds


Gene context of Proportional Hazards Models


Analytical, diagnostic and therapeutic context of Proportional Hazards Models


  1. Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Scheer, S., Chu, P.L., Klausner, J.D., Katz, M.H., Schwarcz, S.K. Lancet (2001) [Pubmed]
  2. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study. Stein, D.S., Graham, N.M., Park, L.P., Hoover, D.R., Phair, J.P., Detels, R., Ho, M., Saah, A.J. Ann. Intern. Med. (1994) [Pubmed]
  3. Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. Doyle, J.J., Neugut, A.I., Jacobson, J.S., Grann, V.R., Hershman, D.L. J. Clin. Oncol. (2005) [Pubmed]
  4. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Ikeda, K., Saitoh, S., Koida, I., Arase, Y., Tsubota, A., Chayama, K., Kumada, H., Kawanishi, M. Hepatology (1993) [Pubmed]
  5. The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer. Foulkes, W.D., Brunet, J.S., Stefansson, I.M., Straume, O., Chappuis, P.O., Bégin, L.R., Hamel, N., Goffin, J.R., Wong, N., Trudel, M., Kapusta, L., Porter, P., Akslen, L.A. Cancer Res. (2004) [Pubmed]
  6. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Hu, G., Lindström, J., Valle, T.T., Eriksson, J.G., Jousilahti, P., Silventoinen, K., Qiao, Q., Tuomilehto, J. Arch. Intern. Med. (2004) [Pubmed]
  7. Serum insulin and incident coronary heart disease in middle-aged British men. Perry, I.J., Wannamethee, S.G., Whincup, P.H., Shaper, A.G., Walker, M.K., Alberti, K.G. Am. J. Epidemiol. (1996) [Pubmed]
  8. Serum folate and risk for coronary heart disease: results from a cohort of US adults. Giles, W.H., Kittner, S.J., Croft, J.B., Anda, R.F., Casper, M.L., Ford, E.S. Annals of epidemiology. (1998) [Pubmed]
  9. Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder. Berger, P., Sachs, G., Amering, M., Holzinger, A., Bankier, B., Katschnig, H. Journal of affective disorders. (2004) [Pubmed]
  10. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. Evans, W.E., Relling, M.V., Rodman, J.H., Crom, W.R., Boyett, J.M., Pui, C.H. N. Engl. J. Med. (1998) [Pubmed]
  11. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. Ramond, M.J., Poynard, T., Rueff, B., Mathurin, P., Théodore, C., Chaput, J.C., Benhamou, J.P. N. Engl. J. Med. (1992) [Pubmed]
  12. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. Osborne, C.K., Bardou, V., Hopp, T.A., Chamness, G.C., Hilsenbeck, S.G., Fuqua, S.A., Wong, J., Allred, D.C., Clark, G.M., Schiff, R. J. Natl. Cancer Inst. (2003) [Pubmed]
  13. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. Karagas, M.R., McDonald, J.A., Greenberg, E.R., Stukel, T.A., Weiss, J.E., Baron, J.A., Stevens, M.M. J. Natl. Cancer Inst. (1996) [Pubmed]
  14. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. Mitsudomi, T., Oyama, T., Kusano, T., Osaki, T., Nakanishi, R., Shirakusa, T. J. Natl. Cancer Inst. (1993) [Pubmed]
  15. Survival in renal vascular disease. Conlon, P.J., Athirakul, K., Kovalik, E., Schwab, S.J., Crowley, J., Stack, R., McCants, C.B., Mark, D.B., Bashore, T.M., Albers, F. J. Am. Soc. Nephrol. (1998) [Pubmed]
  16. Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators. Hallstrom, A.P., McAnulty, J.H., Wilkoff, B.L., Follmann, D., Raitt, M.H., Carlson, M.D., Gillis, A.M., Shih, H.T., Powell, J.L., Duff, H., Halperin, B.D. J. Am. Coll. Cardiol. (2001) [Pubmed]
  17. Coronary artery disease in IDDM. Gender differences in risk factors but not risk. Lloyd, C.E., Kuller, L.H., Ellis, D., Becker, D.J., Wing, R.R., Orchard, T.J. Arterioscler. Thromb. Vasc. Biol. (1996) [Pubmed]
  18. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Ellis, R.J., Deutsch, R., Heaton, R.K., Marcotte, T.D., McCutchan, J.A., Nelson, J.A., Abramson, I., Thal, L.J., Atkinson, J.H., Wallace, M.R., Grant, I. Arch. Neurol. (1997) [Pubmed]
  19. Pharmacodynamic relationship of pharmacokinetic parameters of maintenance doses of foscarnet and clinical outcome of cytomegalovirus retinitis. Jacobson, M.A., Polsky, B., Causey, D., Davis, R., Tong, W., O'Donnell, J.J., Kuppermann, B.D., Heinemann, M.H., Feinberg, J., Lizak, P. Antimicrob. Agents Chemother. (1994) [Pubmed]
  20. Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. Leibovici, D., Grossman, H.B., Dinney, C.P., Millikan, R.E., Lerner, S., Wang, Y., Gu, J., Dong, Q., Wu, X. J. Clin. Oncol. (2005) [Pubmed]
  21. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. El-Serag, H.B., Davila, J.A. Hepatology (2004) [Pubmed]
  22. Body mass index and prognosis in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly. Tuomilehto, J. Am. J. Med. (1991) [Pubmed]
  23. Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts. Ikeda, K., Arase, Y., Saitoh, S., Kobayashi, M., Someya, T., Hosaka, T., Akuta, N., Suzuki, Y., Suzuki, F., Sezaki, H., Kumada, H., Tanaka, A., Harada, H. J. Hepatol. (2006) [Pubmed]
  24. A multivariate analysis of the risk of cytomegalovirus infection in heart transplant recipients. Gorensek, M.J., Stewart, R.W., Keys, T.F., McHenry, M.C., Goormastic, M. J. Infect. Dis. (1988) [Pubmed]
  25. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor. Kieback, D.G., McCamant, S.K., Press, M.F., Atkinson, E.N., Gallager, H.S., Edwards, C.L., Hajek, R.A., Jones, L.A. Cancer Res. (1993) [Pubmed]
  26. Clinicopathological significance of fragile histidine triad transcription protein expression in breast carcinoma. Yang, Q., Yoshimura, G., Suzuma, T., Tamaki, T., Umemura, T., Nakamura, M., Nakamura, Y., Wang, X., Mori, I., Sakurai, T., Kakudo, K. Clin. Cancer Res. (2001) [Pubmed]
  27. Changes in lymphocyte subsets in human immunodeficiency virus-positive persons with < 5 CD4 T lymphocytes/mm3. Sabin, C.A., Mocroft, A., Bofill, M., Janossy, G., Lee, C.A., Johnson, M., Phillips, A.N. J. Infect. Dis. (1998) [Pubmed]
  28. Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Sullivan, J.M., El-Zeky, F., Vander Zwaag, R., Ramanathan, K.B. Am. J. Cardiol. (1997) [Pubmed]
  29. Haematocrit: a predictor of cardiovascular mortality? Erikssen, G., Thaulow, E., Sandvik, L., Stormorken, H., Erikssen, J. J. Intern. Med. (1993) [Pubmed]
  30. Cancer incidence and cancer mortality in relation to serum cholesterol. Törnberg, S.A., Holm, L.E., Carstensen, J.M., Eklund, G.A. J. Natl. Cancer Inst. (1989) [Pubmed]
  31. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Khaw, K.T., Bingham, S., Welch, A., Luben, R., Wareham, N., Oakes, S., Day, N. Lancet (2001) [Pubmed]
  32. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Kark, J.D., Selhub, J., Adler, B., Gofin, J., Abramson, J.H., Friedman, G., Rosenberg, I.H. Ann. Intern. Med. (1999) [Pubmed]
  33. Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study. Nordstrom, B.L., Oh, K., Sacks, S.T., L'Italien, G.J. Antivir. Ther. (Lond.) (2004) [Pubmed]
  34. Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma. Barbare, J.C., Bouché, O., Bonnetain, F., Raoul, J.L., Rougier, P., Abergel, A., Boige, V., Denis, B., Blanchi, A., Pariente, A., Milan, C., Bedenne, L. J. Clin. Oncol. (2005) [Pubmed]
  35. Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia. Verstovsek, S., Kantarjian, H., Manshouri, T., Cortes, J., Giles, F.J., Rogers, A., Albitar, M. Blood (2002) [Pubmed]
  36. Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia. Faderl, S., Do, K.A., Johnson, M.M., Keating, M., O'brien, S., Jilani, I., Ferrajoli, A., Ravandi-Kashani, F., Aguilar, C., Dey, A., Thomas, D.A., Giles, F.J., Kantarjian, H.M., Albitar, M. Blood (2005) [Pubmed]
  37. The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke. Fornage, M., Lee, C.R., Doris, P.A., Bray, M.S., Heiss, G., Zeldin, D.C., Boerwinkle, E. Hum. Mol. Genet. (2005) [Pubmed]
  38. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Schwartz, A.G., Prysak, G.M., Murphy, V., Lonardo, F., Pass, H., Schwartz, J., Brooks, S. Clin. Cancer Res. (2005) [Pubmed]
  39. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Manne, U., Weiss, H.L., Grizzle, W.E. Clin. Cancer Res. (2000) [Pubmed]
  40. Early growth and type 2 diabetes: evidence from the 1946 British birth cohort. Wadsworth, M., Butterworth, S., Marmot, M., Ecob, R., Hardy, R. Diabetologia (2005) [Pubmed]
  41. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Balkau, B., Shipley, M., Jarrett, R.J., Pyörälä, K., Pyörälä, M., Forhan, A., Eschwège, E. Diabetes Care (1998) [Pubmed]
  42. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers. Delahunt, B., Bethwaite, P.B., Nacey, J.N., Ribas, J.L. J. Pathol. (1993) [Pubmed]
  43. Prognostic value of thallium-201 per rectum scintigraphy in alcoholic cirrhosis. Urbain, D., Muls, V., Makhoul, E., Ham, H.R. J. Nucl. Med. (1994) [Pubmed]
  44. Phosphorylated tyrosine-containing proteins in primary lung cancer correlates with proliferation and prognosis. Gong, Y., Hirano, T., Kato, Y., Yoshida, K., Shou, Y., Ohira, T., Ikeda, N., Ebihara, Y., Kato, H. Br. J. Cancer (2002) [Pubmed]
WikiGenes - Universities